Net income up 15 percent at Community West Bancshares
Net income for Community West Bancshares increased nearly 15 percent for the second quarter ended June 30 to $1.6 million, or 18 cents per diluted share. Loans increased to $684.8 million, versus $564.8 million a year ago, and total assets grew 22.2 percent year-over-year to $785 million. Net interest margin dropped slightly, from 4.45 percent Read More →
Read More →Amgen stock drops despite strong earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Sienna stock soars after $65 million IPO
Westlake Village biotechnology company Sienna Biopharmaceuticals closed with a big gain after it raised $65 million in its initial public offering July 27. Sienna priced the 4.33 million shares it offered at $15. Shares had reached $21 around noon before ending at $19.25, a 28.3 percent premium on its opening price. The company operates in Read More →
Read More →Deckers Brands sales up 20 percent year-over-year
Deckers Brands reported a 20.3 percent year-over-year net increase in sales but still had a net loss of $42.1 million for its fiscal first quarter ended June 30. Sales continued to grow in its direct-to-consumer channel, including its Hoka One One brand, and the figure included wholesale shipments of Ugg products originally expected to ship Read More →
Read More →MindBody revenues up but net losses continue
Consistent with its last earnings report, MindBody’s revenues increased 31 percent for its second fiscal quarter 2017, but net losses persisted, reaching $4.4 million, or 10 cents per basic and diluted share. The San Luis Obispo-based software provider for the wellness industry brought in $44.1 million in revenue, including $17.6 million from its payments software. Read More →
Read More →Goleta medical device maker stocks are hot
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen partnering to develop new drugs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →